Galectin Therapeutics Announces Positive Top-Line Results from a Phase 1b Clinical Trial Extension of Belapectin in Combination with KEYTRUDA® in Advanced Metastatic Melanoma and Head and Neck Cancer
Stock Information for Galectin Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.